Quest Diagnostics Incorporated (DGX): Price and Financial Metrics

Quest Diagnostics Incorporated (DGX)

Today's Latest Price: $112.85 USD

0.69 (0.62%)

Updated Feb 14 7:39pm

Add DGX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

DGX Stock Summary

  • Quest Diagnostics Inc's market capitalization of $14,376,219,989 is ahead of 87.63% of US-listed equities.
  • Of note is the ratio of Quest Diagnostics Inc's sales and general administrative expense to its total operating expenses; 78.36% of US stocks have a lower such ratio.
  • The volatility of Quest Diagnostics Inc's share price is greater than that of only 5.58% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to DGX, based on their financial statements, market capitalization, and price volatility, are TIF, PFG, L, HII, and PHM.
  • Visit DGX's SEC page to see the company's official filings. To visit the company's web site, go to
DGX Daily Price Range
DGX 52-Week Price Range

DGX Stock Price Chart More Charts

DGX Price/Volume Stats

Current price $112.85 52-week high $113.00
Prev. close $112.16 52-week low $82.59
Day low $111.71 Volume 670,700
Day high $112.85 Avg. volume 861,016
50-day MA $107.95 Dividend yield 1.88%
200-day MA $103.34 Market Cap 15.20B

Quest Diagnostics Incorporated (DGX) Company Bio

Quest Diagnostics provides diagnostic testing information services in the United States and internationally. The company offers clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services, and drugs-of-abuse testing, as well as related services and insights; laboratory testing services for new drugs, vaccines, and medical devices, analytic, on-site prevention, and wellness services, and risk assessment services for the life insurance industry. The company was founded in 1967 and is founded in Madison, New Jersey.

DGX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

Below please find a table outlining a discounted cash flow forecast for DGX, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Quest Diagnostics Inc ranked in the 50st percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 21%. The most interesting components of our discounted cash flow analysis for Quest Diagnostics Inc ended up being:

  • Quest Diagnostics Inc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than only 20.45% of tickers in our DCF set.
  • As a business, Quest Diagnostics Inc experienced a tax rate of about 16% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than 73.04% of stocks generating free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Quest Diagnostics Inc? See UHS, FTLF, DXCM, ANGO, and LH.

DGX Latest News Stream

Event/TimeNews Detail
Loading, please wait...

DGX Latest Social Stream

Loading social stream, please wait...

View Full DGX Social Stream

DGX Price Returns

1-mo 5.41%
3-mo 8.55%
6-mo 10.51%
1-year 31.24%
3-year 25.24%
5-year 74.99%
YTD 6.20%
2019 31.13%
2018 -13.84%
2017 9.16%
2016 31.90%
2015 8.37%

DGX Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full DGX Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.6339 seconds.